Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y

被引:775
作者
Pavel, M. [1 ]
Oberg, K. [2 ]
Falconi, M. [3 ]
Krenning, E. P. [4 ]
Sundin, A. [5 ]
Perren, A. [6 ]
Berruti, A. [7 ]
机构
[1] Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany
[2] Uppsala Univ, Dept Endocrine Oncol, Uppsala, Sweden
[3] IRCCS San Raffaele Sci Inst, Dept Surg, Milan, Italy
[4] Cyclotron Rotterdam BV, Erasmus Med Ctr, Rotterdam, Netherlands
[5] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[6] Univ Bern, Inst Pathol, Bern, Switzerland
[7] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol Unit, ASST Spedali Civili, Brescia, Italy
关键词
RECEPTOR RADIONUCLIDE THERAPY; ENETS CONSENSUS GUIDELINES; LIVER METASTASES; OCTREOTIDE-LAR; PHASE-III; GA-68-DOTA-TYR(3)-OCTREOTIDE PET; GASTROINTESTINAL-TRACT; TYR(3) OCTREOTATE; ENDOCRINE TUMORS; DOUBLE-BLIND;
D O I
10.1016/j.annonc.2020.03.304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:844 / 860
页数:17
相关论文
共 106 条
[1]  
Anderson MA, 2000, AM J GASTROENTEROL, V95, P2271
[2]  
[Anonymous], 2019, BREAST TUMOURS, V5th
[3]   Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity [J].
Antonodimitrakis, Pantelis Clewemar ;
Sundin, Anders ;
Wassberg, Cecilia ;
Granberg, Dan ;
Skogseid, Britt ;
Eriksson, Barbro .
NEUROENDOCRINOLOGY, 2016, 103 (3-4) :345-353
[4]   18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors [J].
Binderup, Tina ;
Knigge, Ulrich ;
Loft, Annika ;
Federspiel, Birgitte ;
Kjaer, Andreas .
CLINICAL CANCER RESEARCH, 2010, 16 (03) :978-985
[5]   PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest [J].
Bodei, Lisa ;
Kidd, Mark S. ;
Singh, Aviral ;
van der Zwan, Wouter A. ;
Severi, Stefano ;
Drozdov, Ignat A. ;
Malczewska, Anna ;
Baum, Richard P. ;
Kwekkeboom, Dik J. ;
Paganelli, Giovanni ;
Krenning, Eric P. ;
Modlin, Irvin M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) :895-906
[6]   PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy [J].
Bodei, Lisa ;
Kidd, Mark S. ;
Singh, Aviral ;
van der Zwan, Wouter A. ;
Severi, Stefano ;
Drozdov, Ignat A. ;
Cwikla, Jaroslaw ;
Baum, Richard P. ;
Kwekkeboom, Dik J. ;
Paganelli, Giovanni ;
Krenning, Eric P. ;
Modlin, Irvin M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) :1155-1169
[7]   Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors [J].
Brabander, Tessa ;
van der Zwan, Wouter A. ;
Teunissen, Jaap J. M. ;
Kam, Boen L. R. ;
Feelders, Richard A. ;
de Herder, Wouter W. ;
van Eijck, Casper H. J. ;
Franssen, Gaston J. H. ;
Krenning, Eric P. ;
Kwekkeboom, Dik J. .
CLINICAL CANCER RESEARCH, 2017, 23 (16) :4617-4624
[8]   Pancreatic neuroendocrine tumor: Added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection [J].
Brenner, Renata ;
Metens, Thierry ;
Bali, Maria ;
Demetter, Pieter ;
Matos, Celso .
EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (05) :E746-E749
[9]  
Brierley J.D., 2016, TNM classification of malignant tumours
[10]   Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review [J].
Broder, Michael S. ;
Beenhouwer, David ;
Strosberg, Jonathan R. ;
Neary, Maureen P. ;
Cherepanov, Dasha .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) :1945-1955